Our results were partly supported by findings from a previous study, where the authors found that reducing glutamine metabolism (loss-of-function of GLS2) in the liver resulted in decreased severity of hyperglycaemia (increased plasma levels of glutamine and reduced levels of fasting glucose) [43]. The gene discussed is GLS2; the disease is Hyperglycemia.